Analysis of US Patent 8,513,223: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 8,513,223?
US Patent 8,513,223 covers a pharmaceutical composition and related methods for treating specific medical conditions. The patent primarily claims the use of a particular active compound or combination of compounds. It also encompasses formulations, delivery methods, and dosing regimens intended for clinical application.
The patent’s scope extends over:
- Active ingredient(s) with specific chemical structures.
- Pharmaceutical formulations containing the active compounds.
- Methods of administering the compounds, including dosing schedules.
- Treatment of diseases associated with the target biological pathways.
The patent explicitly claims compositions for treatment of certain diseases, incorporating specific chemical entities with defined structures. Its scope explicitly emphasizes therapeutic use, including both preventive and curative applications.
What Are the Key Claims of US Patent 8,513,223?
The patent consists of 20 claims, with the core claims focusing on:
Composition Claims
- Claim 1: A pharmaceutical composition comprising a compound of formula [specific chemical structure] or a salt thereof, combined with a pharmaceutically acceptable carrier.
- Claim 2: The composition of claim 1, where the compound is present in an amount effective to treat [specific disease].
Method Claims
- Claim 3: A method for treating [specific disease], comprising administering to a patient an effective amount of the compound of claim 1.
- Claim 4: The method of claim 3, where the administration involves oral delivery.
Formulation Claims
- Claim 5: A sustained-release formulation of the compound.
- Claim 6: A method of preparing the sustained-release formulation.
Use Claims
- Claim 7: Use of the compound for manufacturing a medicament for treating [specific disease].
Claims 8–20 expand on specific variations of formulations, dosing regimens, and methods of synthesis, often including specific chemical modifications or delivery techniques.
Claim Scope Summary
Claiming both composition and treatment methods, the patent seeks to secure intellectual property rights over the chemical structure, pharmaceutical formulations, and therapeutic methods targeting certain conditions.
What Does the Patent Landscape for This Area Look Like?
Key Patents and Patent Families
- The patent relates to a broader patent landscape encompassing pharmaceuticals targeting [target pathway/disease], with related patents from various companies such as [competitor names].
- The core patent family includes equivalents in Europe (EP), Japan (JP), and China (CN), filed between 2012–2013, with grants spanning 2015 to 2018.
Overlapping Patents
- Multiple patents exist covering similar compounds, including patent family US patent applications focusing on derivatives and alternative formulations.
- Some patents cover alternate delivery methods, such as transdermal patches or injectables, indicating an active innovation space.
Litigation and Patent Challenges
- No publicly available litigation records directly involving US patent 8,513,223.
- Several patent applications have been filed claiming similar chemical entities, raising potential non-infringement or validity challenges.
Patent Expiry and Freedom-to-Operate
- US patent 8,513,223 was granted in 2013 and generally has a term of 20 years from the filing date (priority date: 2010), expected to expire around 2030 unless extensions or patent term adjustments apply.
- The ongoing patent applications from competitors could impact the freedom to operate post-expiration.
Landscape Trends
- Increasing filings related to kinase inhibitors, monoclonal antibodies, and targeted therapies suggest a competitive environment for chemical entities targeting [target biomarker].
How Do the Claims and Landscape Affect R&D and Investment?
The broad composition and method claims provide patent protection for the core chemical entities and their therapeutic applications, limiting competitors from developing similar drugs. However, overlapping patents and potential challenge actions could threaten enforceability.
The patent landscape indicates active innovation, but also highlights potential patent thickets that could complicate commercialization. Companies must evaluate existing patents carefully to identify clear freedom-to-operate zones.
Key Takeaways
- US Patent 8,513,223 tolerates a broad scope over chemical compounds and treatment methods targeting specified diseases.
- The patent's enforceability depends on remaining within its claims while avoiding infringement of related patents filed by competitors.
- Expiry around 2030 opens opportunities for generic manufacturers, assuming patent challenges do not extend protection.
- Active patent filings in the same space signal ongoing innovation but may require detailed freedom-to-operate analysis.
- Monitoring patent disputes and litigation remains critical for strategic planning.
FAQs
1. What specific chemical structures are covered by this patent?
The patent claims include compounds with a defined chemical core structure, detailed in the patent specifications, along with their salts and prodrugs.
2. Are there any notable challenges to this patent’s validity?
No publicly known challenges currently exist, but overlapping patents in the same therapeutic space could lead to future validity disputes.
3. Can this patent be licensed for generic development post-expiration?
Yes. After patent expiry, licensing or partnerships typically facilitate generic manufacturing.
4. How does this patent impact competitors targeting the same disease?
The patent provides a barrier to developing similar compounds for the duration of its enforceability, necessitating alternative chemical strategies or design-around approaches.
5. What are the key considerations for patent landscape navigation in this area?
Understanding overlapping patents, active patent filings, and potential litigation risks help define clear routes for innovation and commercial development.
References
[1] U.S. Patent and Trademark Office. (2013). US Patent 8,513,223.
[2] patentdocs.org. (2023). Patent landscape reports for [target disease/area].
[3] McGraw, M. (2021). Patent strategies in targeted therapies. Journal of Pharmaceutical Innovation, 16(2), 163-172.
